Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

NICE recommends Bayer’s Eylea for myopic chorodial neovascularisation

September 22, 2017 Medical Communications, Sales and Marketing Bayer, Eylea, NICE, pharma, pharmaceutical

Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea (aflibercept solution …
News

Merck and Pfizer’s joint skin cancer drug gets EU approval

September 21, 2017 Sales and Marketing Bavencio, Cancer, Merck, Pfizer, merkel cell carcinoma, pharma, pharmaceutical, skin canceer

Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in …
News

Bayer pulls plug on sterilisation device after numerous complaints

September 21, 2017 Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical

Bayer has stopped the commercial sale of a sterilisation device in all countries, except the US, after reports that it …
News

Novartis scores EU approval in acute myeloid leukaemia and advanced systemic mastocytosis

September 20, 2017 Research and Development, Sales and Marketing EU, Europe, Novartis, acute myeloid leukaemia, advanced systemic mastocytosis, pharma, pharmaceutical

Novartis has announced that its targeted therapy Rydapt (midostaurin) has received EU approval in the two rare cancer indications: newly …
News

Gates Foundation invest in Immunocore, warning of infectious disease threat

September 20, 2017 Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, infectious diseases, pharma, pharmaceutical

It has been announced that the Bill & Melina Gates Foundation will invest up to $40 million in UK-based Immunocore …
News

BMS’ Opdivo to finally be made available to lung cancer patients in the UK

September 20, 2017 Research and Development, Sales and Marketing Bristol-Myers Squibb, NICE, biotech, drugs, opdivo, pharma, pharmaceutical

It is two and a half years since patients with lung cancer in the US were able to receive Bristol-Myers …
News

GSK gets FDA approval for key triple therapy inhaler

September 20, 2017 Research and Development, Sales and Marketing GSK, Trelegy Ellipta, biotech, drugs, pharma, pharmaceutical

The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler.
News

Janssen reveals positive CHMP opinion, long-term data for psoriasis drug guselkumab

September 19, 2017 Manufacturing and Production, Research and Development, Sales and Marketing EMA< CHMP, Janssen, guselkumab, pharma, pharmaceuticals

Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal …
News

FDA locks down combo immunotherapy trials, Roche added to hold

September 19, 2017 Manufacturing and Production, Sales and Marketing Roche, biotech, drugs, immunotherapy, pharma, pharmaceutical, tecentriq

The FDA has moved to ensure that all immunotherapy trials studying PD-1/L1 agents, alongside immunomodulatory medicines in certain blood cancers …
News

Teva completes sale of women’s health for $1.38 billion

September 19, 2017 Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical, women's health

Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for …
News

Scholar Rock prise Regulatory Affairs director away from Biogen

September 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Scholar Rock, biotech, drugs, pharma, pharmaceutical

Scholar Rock has announced that it has moved to appoint Heather Faulds as Vice President of Regulatory Affairs. Faulds joins …
Appointment

Novartis’ Xolair shows strong retreatment efficacy at Phase 3 in chronic spontaneous urticaria

September 18, 2017 Research and Development, Sales and Marketing Novartis, Xolair, chronic spontaneous urticarial, pharma, pharmaceutical

Novartis has released new data demonstrating the efficacy of Xolair (omalizumab) in the treatment of chronic spontaneous urticaria (CSU), a …
News

Standing together: Supercharging the clinical trial in Europe

September 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, clinical trials, drugs, pharma, pharmaceutical

The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating …
Feature

FDA approves first medical app, for use in addiction

September 18, 2017 Sales and Marketing Pear Therapeutics, biotech, drugs, pharma, pharmaceutical, reset

The FDA has taken a major step in the digitisation of healthcare by handing out the first medical app approval: …
News

China’s Fosun Group grabs 74% stake in India’s Gland Pharma for $1.1 billion

September 18, 2017 Sales and Marketing China, Fosun Pharma, Gland Pharma, India, pharma, pharmaceuticals

Chinese conglomerate Fosun has agreed to acquire 74% of India’s Gland Pharma for $1.1 billion, sealing a previously unsuccessful deal …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026